Publications (47) Cuesta AM publications

filter_list

2025

  1. Correction: Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis (Cell Death & Disease, (2025), 16, 1, (711), 10.1038/s41419-025-08031-y)

    Cell Death and Disease

  2. Deletion of C3G in hepatocytes impairs full liver maturation and alters glucose homeostasis

    Cell Death and Disease, Vol. 16, Núm. 1

  3. Inmunoterapia en acción: Estrategias innovadoras contra el glioblastoma multiforme

    Anales de la Real Academia Nacional de Farmacia, Vol. 91, Núm. 1, pp. 45-65

  4. Platelet C3G protects from liver fibrosis, while enhancing tumor growth through regulation of the immune response

    Journal of Pathology, Vol. 265, Núm. 4, pp. 502-517

2024

  1. CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel essential gene in prostate cancer metastasis

    Cancer Letters, Vol. 588

  2. Effect of 5β-dihydrotestosterone on vasodilator function and on cell proliferation

    PLoS ONE, Vol. 19, Núm. 10 October

  3. Endothelial-to-Mesenchymal Transition in an Hereditary Hemorrhagic Telangiectasia-like Pediatric Case of Multiple Pulmonary Arteriovenous Malformations

    International Journal of Molecular Sciences, Vol. 25, Núm. 11

  4. Hacia una pedagogía innovadora y actual: evaluación del uso de la inteligencia artificial en estudiantes de farmacia de la Universidad Complutense de Madrid

    Revolucionando la docencia universitaria: innovación educativa en la era de la IA y la gamificación (Dykinson), pp. 468-483

  5. Molecular and Cellular Characterization of Primary Endothelial Cells from a Familial Cavernomatosis Patient

    International Journal of Molecular Sciences, Vol. 25, Núm. 7

2023

  1. Mutation in Chek2 triggers von Hippel-Lindau hemangioblastoma growth

    Acta Neurochirurgica, Vol. 165, Núm. 12, pp. 4241-4251

  2. New and Old Key Players in Liver Cancer

    International Journal of Molecular Sciences, Vol. 24, Núm. 24

2022

  1. A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2

    Journal of Clinical Medicine, Vol. 11, Núm. 11

  2. C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process

    International journal of biological sciences, Vol. 18, Núm. 15, pp. 5873-5884

  3. Hereditary Hemorrhagic Telangiectasia: Diagnosis and Management

    Journal of Clinical Medicine

  4. Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

    Journal of Clinical Medicine, Vol. 11, Núm. 15

  5. The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases

    International Journal of Molecular Sciences, Vol. 23, Núm. 8

2020

  1. CLN5 in heterozygosis may protect against the development of tumors in a VHL patient

    Orphanet Journal of Rare Diseases, Vol. 15, Núm. 1

  2. Review of pharmacological strategies with repurposed drugs for hereditary hemorrhagic telangiectasia related bleeding

    Journal of Clinical Medicine, Vol. 9, Núm. 6, pp. 1-22

  3. Targeting β2-adrenergic receptors shows therapeutical benefits in clear cell renal cell carcinoma from von Hippel–Lindau disease

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-30

2019

  1. Deep Learning Reveals Cancer Metastasis and Therapeutic Antibody Targeting in the Entire Body

    Cell, Vol. 179, Núm. 7, pp. 1661-1676.e19